Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 45, Issue 8 (Aug 2007)

Issues

Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples

Michael Vogeser
  • 1Institute of Clinical Chemistry, Hospital of the University of Munich, Munich, Germany
/ Gustav Schelling
  • 2Department of Anesthesiology, Hospital of the University of Munich, Munich, Germany
Published Online: 2007-08-09 | DOI: https://doi.org/10.1515/CCLM.2007.197

Abstract

Background: The endocannabinoid 2-arachidonoyl glycerol (2-AG) undergoes spontaneous isomerization to biologically inactive 1-AG. This effect has not been adequately addressed in previous studies that reported 2-AG concentrations in biological samples.

Methods: Liquid chromatography tandem-mass spectrometry (LC-MS/MS) was used for 1-AG and 2-AG analyses.

Results: Identical collision-induced disintegration spectra were found for 1-AG and 2-AG. For specific detection of both compounds, which share a common mass transition, baseline chromatographic separation is mandatory, even when applying MS/MS technology with its generally high detection specificity. When using standard chromatographic conditions with the very short run times typically used in LC-MS/MS methods, co-elution of 2-AG with 1-AG, which is present in human serum, causes false 2-AG results.

Conclusions: Our data highlight that the analytical specificity of MS/MS can be limited by interference from isobaric isomers with identical disintegration patterns. The specificity of this technology must be carefully evaluated for each individual application.

Clin Chem Lab Med 2007;45:1023–5.

Keywords: 1-arachidonoyl glycerol (1-AG); 2-arachidonoyl glycerol (2-AG); endocannabinoids; interference; isomers; liquid chromatography tandem-mass spectrometry (LC-MS/MS)

About the article

Corresponding author: Michael Vogeser, MD, Institute of Clinical Chemistry, Hospital of the University of Munich, Marchioninistraße 15, 81377 Munich, Germany Phone: +49-89-70953221, Fax: +49-89-70953240,


Received: 2007-02-01

Accepted: 2007-05-03

Published Online: 2007-08-09

Published in Print: 2007-08-01


Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2007.197. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Angela Holtfrerich, Teona Makharadze, and Matthias Lehr
Analytical Biochemistry, 2010, Volume 399, Number 2, Page 218
[2]
M. Feuerecker, D. Hauer, T. Gresset, S. Lassas, I. Kaufmann, M. Vogeser, J. Briegel, C. Hornuss, A. Chouker, and G. Schelling
Alcohol and Alcoholism, 2012, Volume 47, Number 3, Page 226
[3]
P. Atsak, D. Hauer, P. Campolongo, G. Schelling, J. L. McGaugh, and B. Roozendaal
Proceedings of the National Academy of Sciences, 2012, Volume 109, Number 9, Page 3504
[4]
M. Feuerecker, D. Hauer, R. Toth, F. Demetz, J. Hölzl, M. Thiel, I. Kaufmann, G. Schelling, and A. Choukèr
European Journal of Applied Physiology, 2012, Volume 112, Number 7, Page 2777
[5]
Michael Vogeser and Christoph Seger
Clinical Biochemistry, 2008, Volume 41, Number 9, Page 649
[6]
Sarah Trimpin, Bo Tan, Brian C. Bohrer, David K. O’Dell, Samuel I. Merenbloom, Mauricio X. Pazos, David E. Clemmer, and J. Michael Walker
International Journal of Mass Spectrometry, 2009, Volume 287, Number 1-3, Page 58
[7]
Alexander A. Zoerner, Frank-Mathias Gutzki, Sandor Batkai, Marcus May, Christin Rakers, Stefan Engeli, Jens Jordan, and Dimitrios Tsikas
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011, Volume 1811, Number 11, Page 706
[8]
Ines Kaufmann, Gustav Schelling, Christoph Eisner, Hans Peter Richter, Till Krauseneck, Michael Vogeser, Daniela Hauer, Patrizia Campolongo, Alexander Chouker, Antje Beyer, and Manfred Thiel
Psychoneuroendocrinology, 2008, Volume 33, Number 5, Page 676
[9]
Florian Weis, Andres Beiras-Fernandez, Ralf Sodian, Ingo Kaczmarek, Bruno Reichart, Andres Beiras, Gustav Schelling, and Simone Kreth
Journal of Molecular and Cellular Cardiology, 2010, Volume 48, Number 6, Page 1187
[10]
Carmelo Quarta, Roberta Mazza, Silvana Obici, Renato Pasquali, and Uberto Pagotto
Trends in Molecular Medicine, 2011, Volume 17, Number 9, Page 518
[11]
Alexander A. Zoerner, Frank M. Gutzki, Maria T. Suchy, Bibiana Beckmann, Stefan Engeli, Jens Jordan, and Dimitrios Tsikas
Journal of Chromatography B, 2009, Volume 877, Number 26, Page 2909
[12]
F. Weis, A. Beiras-Fernandez, D. Hauer, C. Hornuss, R. Sodian, S. Kreth, J. Briegel, and G. Schelling
British Journal of Anaesthesia, 2010, Volume 105, Number 2, Page 139
[13]
Kalpana S. Paudel, Jing Chen, and Audra L. Stinchcomb
Chromatographia, 2010, Volume 71, Number 1-2, Page 65

Comments (0)

Please log in or register to comment.
Log in